SpicyIP Tidbit: Limit on applications(1000) for expedited patent examination
Om Prakash Gupta, the Controller General of Patents, Designs and Trade Marks, issued a notice which stated, without any reasoning, that the number of applications for expedited examination of patent...
View ArticleTwenty Minutes to Copyright Infringement
We have in the past covered innumerable instances of copyright infringement allegations brought against Bollywood movies either from major Hollywood studios or producers in the south. To bring...
View ArticleMusings on Phishy Copyright Societies
A recent incident with a Spicy IP friend in UK got us musing on one of our pet peeves on this blog, copyright collecting societies. Imagine you are an academic who has published a few books available...
View ArticleOf judicial [un]appointments, double standards and the United States’...
In what is being called a legitimacy crisis, the WTO faces the vacation of two Appellate Body (AB) seats as the United States has, in an unprecedented move – opposed the re-appointment of Mr. Seung Wha...
View ArticleFlying cars in India by 2018?
[This post was co-authored with Madhulika Vishwanathan] Flying cars. We’ve grown up with the fantasy – the Jetsons, Harry Potter, and then a flurry of sci-fi movies. We’ve all watched enthralled as...
View ArticleUltratech Cement versus Dalmia Cement: Bombay High Court on Protection of...
In a fairly straightforward case of trademark infringement and passing off, Justice S.C. Gupte of the Bombay High Court dismissed the plaintiff’s application for interim relief on the ground that there...
View ArticleGovernment relaxes FDI norms in Pharma
The government has recently allowed up to 74% Foreign Direct Investment (“FDI”) in existing pharmaceutical companies (brownfield investment) through the automatic route. 100% FDI is already permitted...
View ArticleBacking Up the Start-Up: Benefits of a Sound IPR Strategy
We bring to you a guest post by Sonia Chauhan, an associate at Talwar Advocates. In this post she discusses the benefits of having an IP strategy in place for start ups at an early stage and the...
View ArticleSampling Infringement: Bieber’s ‘Sorry’ Controversy (Part I)
“Is it too late now to say sorry?”“Yes”. Following close on the heels of the Los Angeles District Court’s historic decision last year in the ‘Blurred Lines’ copyright infringement scandal, comes...
View ArticleSampling Infringement: Bieber’s ‘Sorry’ Controversy (Part II)
(Part I can be accessed here) Both Bieber and Skrillex have vehemently refuted allegations that the riff comprises an act of digital sampling – Skrillex recently even tweeted a video in an attempt to...
View ArticleIs obscurity a greater risk than piracy?
The not-so-obscure pirate What better time to take up this debate than now when Anurag Kashyap, the director of Udta Punjab, has himself said that he does not care two hoots about the movie being...
View ArticleSpicyIP Weekly Review (19-25 June)
Our Highlight of the Week was quite clearly Shan’s important announcement of the Government now allowing upto 74% Foreign Direct Investment in existing pharmaceutical companies through the automatic...
View ArticleUNDP Releases Guidelines for Pharma Patent Examination from a Public Health...
The United Nations Development Programme (UNDP) has published a new set of guidelines for patent examination with a primary view to sieve poor and weak pharmaceutical applications out of the patent...
View ArticleBrexit in Times of Caution
Brexit and the World “We have become so used to Nanny in Brussels that we have become infantilized, incapable of imagining an independent future. We used to run the biggest empire the world has ever...
View ArticleUdta Punjab: Of Courts, Cuts, Copyrights and Conflicted Counsels
Udta Punjab continues to soar at the box office. Thanks in no small part to the free publicity engineered by Pahlaj Nihalani and his “cutting” edge crew at the Central Board of Film Certification...
View ArticleJustice Manmohan Singh’s flawed judgment on biosimilars
In this post, Prashant Reddy examines Justice Manmohan Singh’s judgment in the lawsuit filed by Genentech and Roche against Biocon and Mylan over the launch of a biosimilar for Herceptin ®. Prashant,...
View ArticleKriti: “Creation” or Copy?
On the 22nd of June, a short film named “Kriti” was released on YouTube amongst much pomp and flare. Kriti is a psychological thriller directed by Shirish Kunder, and stars Manoj Bajpayee and Radhika...
View ArticleDreaming Deep – Artificial Intelligence and the Future of Copyright, Part II
A DeepDream Creation; Source: https://www.youtube.com/watch?v=6IgbMiEaFRY In the first post in this series, we saw how evolution in Artificial Neural Networks has led to the blurring the lines of...
View ArticleDreaming Deep – Artificial Intelligence and the Future of Copyright, Part I
A DeepDream Creation; Source: https://www.youtube.com/watch?v=6IgbMiEaFRY One of the most popular buzz words in recent times has been Artificial Intelligence (‘A.I’) – and as fascinating, and...
View ArticleConstitutional Validity of US Patent Opposition Proceedings Assailed before...
One of the most vexed issues in the adjudication of patent disputes in India has consistently been the legal competence and professional training of the officers in the Patent Office who are tasked...
View Article